---
title: "Lantern Pharma posts investor presentation on AI-driven oncology drug development platform and pipeline"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291460055.md"
description: "Lantern Pharma released an investor presentation detailing its AI-driven oncology platform, RADR, which claims 88% accuracy in patient stratification and aims to reduce development timelines by 70%. The company highlighted LP-300 for NSCLC, reporting strong interim Phase 2 data with an 86% clinical benefit rate. Additionally, LP-184 completed Phase 1a enrollment, LP-284 is in Phase 1, and the PredictBBB model shows 94% accuracy in predicting blood-brain barrier permeability."
datetime: "2026-07-01T20:36:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291460055.md)
  - [en](https://longbridge.com/en/news/291460055.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291460055.md)
generator: "portal-rs"
---

# Lantern Pharma posts investor presentation on AI-driven oncology drug development platform and pipeline

-   Lantern Pharma highlighted its AI platform RADR, citing 88% accuracy for patient stratification to support targeted oncology trials. \* Management framed RADR as a lever to cut early-stage development timelines by 70% and costs by 80%. \* LP-300 NSCLC program remains in Phase 2; interim data cited an 86% clinical benefit rate and 87% disease control rate as of May 11, 2026. \* Trial focus shifted to EGFR exon 21 L858R; median PFS cited at 8.4 months with target lesion decreases in over 70% of evaluable patients. \* LP-184 completed Phase 1a enrollment; LP-284 is in Phase 1; PredictBBB cited 94% benchmark accuracy for blood-brain barrier permeability prediction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantern Pharma Inc. published the original content used to generate this news brief on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LTRN.US](https://longbridge.com/en/quote/LTRN.US.md)

## Related News & Research

- [3 forgotten AI stocks that should rebound from their corrections](https://longbridge.com/en/news/298812719.md)
- [How Meta tried, and failed, to grab its employees' data for AI](https://longbridge.com/en/news/298706095.md)
- [Anthropic's AI fluency chief says the best AI users know when to do the work themselves](https://longbridge.com/en/news/298433044.md)
- [Albacross-backed Green AI launches 360-degree AI factory energy audit service](https://longbridge.com/en/news/298311301.md)
- [An NEA partner says not every AI task needs frontier intelligence](https://longbridge.com/en/news/298434703.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**